Brilliant Violet 605™ anti-mouse CD62L 104438 from BioLegend

Product Specs
ItemBrilliant Violet 605™ anti-mouse CD62L
CompanyBioLegend
Price $273.00Supplier Page View Company Product Page
Catalog Number104438
Quantity50 µg
ApplicationsFC - Quality tested
Concentrationµg sizes: 0.2 mg/mLµL sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Conjugate/TagBrilliant Violet 605™
FormatPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
ReactivityMouse
IsotypeRat IgG2a, kappa
CloneMEL-14
HostRat
Antibody TypePrimary
ImmunogenC3H/eb mouse B lymphoma 38C-13
NCBI Full Gene Nameselectin, lymphocyte
NCBI Gene AliasesCD62L, L-selectin, LAM-1, LECAM-1, LECAM1, Lnhr, Ly-22, Ly-m22, Lyam-1, Lyam1
ClonalityMonoclonal
TargetCD62L

Add to Compare List

BioLegend

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

Company Profile

Website: biolegend.com

(1) Metabolomics of in vivo inflammation identifies soluble sialic acid as a conserved myeloid-cell metabolitebioRxivJuly 7, 2026Helen A. Jordan, Joseph A. Tandurella, Vineeth Vengayil, Tanay S. Parnaik, Swechha Mainali Mainali Pokharel, Kathleen Mulka, Sara Cherry, E. John Wherry, Caroline R. BartmanBD Biosciences item 564399, anti-KLRG1-BUV805 BD Biosciences item 741993, anti-CD62L-BV605 Biolegend item 104437, anti-CX3CR1-BV650 Biolegend item 149027, anti-CD39-BV711 BD Biosciences item 567295, anti-Vα2-BV750

(2) CD38 defines a therapeutically targetable pathogenic T cell population for precision immunotherapy in autoimmune diabetesbioRxivJuly 3, 2026Shiva Pathak, Rizwan Ahmed, Nadine Nagy, Sooyeon Lee, Cameron S. Bader, Shobha Regmi, Bettina P. Iliopoulou, Pin-I Chen, Biki Gupta, Alejandro Villar-Prados, et al.(AF700)-conjugated CD44 (BioLegend; Cat. 103026), Brilliant Violet 605 (BV605)-conjugated CD62L (BioLegend; Cat. 104438), Fluorescein isothiocyanate (FITC)-conjugated CD38 (BioLegend; Cat. 102705), PB-conjugated Foxp3 (BioLegend,

(3) Removal of CD5 on T cells alters their differentiation and cytokine production in an in vitro model investigating effects of P. gingivalis LPS on oral epithelial and immune cellsFront ImmunolJune 10, 2026Carlos Moreno, Alina Svitlana Rodriguez Bezruchko, Dallin Cardon, Claudia M. Tellez Freitas, K. Scott Weber(47-0041-82, Invitrogen), CD8a-PeCy5.5 (35-0081-82, Thermofisher), CD44-APC (103012, Biolegend), CD62L-BV605 (104438, Biolegend), CCR7-AlexaFluor700 (56-1971-82, Thermofisher), CD69-FITC (104506, Biolegend), and CD25-APC

(4) Senescent Cell Derived Artificial Vesicle‐Based Senolytic Sonovaccine Platform with Augmented Lymph Node Delivery and Antigen Cross‐Presentation EfficacyAdvanced ScienceMay 20, 2026Liang Zhang, Yubo Lai, Jia Wang, Lingling Liu, Jieyuan An, Mi Qu, Yuan Liang, Bijun Tan, Guodong Yang, Xuekang Yang, et al.(103130), CD3‐FITC (100204), CD4‐APC (100412), CD8a‐PE (100708), CD44‐BV650 (103049), CD62L‐BV605 (104438), Zombie Aqua Fixable Viability Kit (423101), TruStain FcX (101320), cell staining buffer (420201),

(5) Ambient temperature regulates CD4+ T cell tonic T cell receptor signaling and responsivenessiScienceMay 15, 2026Keisuke Sawada, John Eom, Bree A. Mahoney-Sutherland, Traci E. Stankiewicz, Jarren R. Oates, Daniel A. Giles, Pablo C. Alarcon, Michelle S.M.A. Damen, Angela Cannata, Julie Hargis, et al.103128; RRID: AB_493715; final concentration: 5 μg/mL), CD62L-BV605 (BioLegend; clone: MEL-14; cat: 104438; RRID: AB_2563058; final concentration: 2 μg/mL), CD69-PE/Cy7 (BioLegend; clone: H1.2F3; cat: 104512;

(6) Proteostasis sustains T cell differentiation potential and tumor-infiltrating lymphocyte functionCellMay 14, 2026Nicole E. Scharping, Xuezhen Ge, Maria Inês Matias, Fulin Jiang, Allison Cafferata, Maximilian Heeg, Alexander Monell, Giovanni Galletti, Kitty P. Cheung, Angelica Rock, et al.Cy7,eBioscience,Cat# 25-1271-82; RRID: AB_469649 anti-mouse CD62L Brillant Violet 605,Biolegend,Cat# 104437; RRID: AB_11125577 anti-mouse THY1.1 Brillant Violet 650,Biolegend,Cat# 202533; RRID: AB_2562254 anti-mouse

(7) VoxelCoder: Classification of human cellular phenotypes via autoencoder batch alignment and hyperdimensional representation of cytometry dataPatterns (N Y)May 8, 2026Benjamin S. Mashford, Timothy Hewitt, Maryam May, Zixin Zhuang, Akshat Jain, Koula E.M. Diamand, Fei-Ju Li, Kristy Kwong, Stuart H. Read, Ainsley R. Davies, et al.# CD3,FITC,200,200,300,BioLegend,100204 CD25,PE,400,400,400,BioLegend,102008 CD8,CD8,100,400,400,BD,563786 CD44,PacBlue,100,400,400,BioLegend,103020 CD62L,BV605,400,600,600,BioLegend,104438 CD19,BV510,600,800,800,BioLegend,115546 IgD,PerCPCy5.5,200,800,800,BD,564273 IgM,R718,100,100,600,BD,752171 NK1.1,APC,200,400,600,BD,550627 Ly6C,PECy7,200,200,400,BioLegend,128018 B220,BUV737,300,600,800,BD,612838 CD4,AF700,200,300,600,BioLegend,100430 Live/Dead,ef780,400,600,800,Thermo Fisher

(8) KLF2 controls thymic epithelial cell homeostasis, impacting regulatory T cell development and immune toleranceiScienceApril 17, 2026Pedro Ferreirinha, Pedro M. Rodrigues, Francisco Sobral, Bruno Cavadas, Nuno L. AlvesAB_2565843 CD44,Biolegend,103022; RRID: AB_10734244 CD5,Biolegend,100605; RRID: AB_312734 CD62L,Biolegend,104437; RRID: AB_11125577 CD69,Biolegend,104511; RRID: AB_493565 CD8,Biolegend,100741; RRID: AB_11124344 FoxP3,Invitrogen,17-5773-80;

(9) Expansion and mobilization of virus-specific stem-like CD8 T cells in chronic viral infection after treatment with a long-acting IL-7, NT-I7Cell ReportsApril 1, 2026Judong Lee, Christina Niavi, Eunseon Ahn, Haydn T. Kissick, Rajesh M. Valanparambil, Tahseen H. Nasti, Donald J. McGuire, Daniel Hua, Rebecca Obeng, Alexandra A. Wolfarth, et al.RRID:AB_2870126 anti-CD44 RB545 (clone:IM7),BD,Cat#:756642; RRID:AB_3688852 anti-CD62L BV605 (clone:MEL-14),Biolegend,Cat#:104438; RRID:AB_2563058 anti-CD62L BV711 (clone:MEL-14),Biolegend,Cat#:104438; RRID:AB_2563058 anti-CD69

(10) Sulfur partitioning from cysteine controls T cell proliferation and effector functionCellMarch 31, 2026Beth Kelly, Minsun Cha, Tatjana Gremelspacher, Jacob L. Martin, Massimo Andreis, Isha Maloo, Gustavo E. Carrizo, Mia Gidley, Michal A. Stanczak, Petya Apostolova, et al.(clone IM7, Biolegend, 103040, 103006, 103008, 103012), anti-CD62L (clone MEL-14, Biolegend, 104424, 104438, 104453), anti-CD69 (clone H1.2F3, Biolegend, 104508), anti-CD45.1 (clone A20, Biolegend, 110739, 110718),

(11) Fluorescence tracking Treg movement identifies anti-CCR8 and radiation as a therapeutic combinationiScienceFebruary 20, 2026David J. Friedman, Sina Ramin, Tiffany Blair, Gwen Kramer, Shelly Bambina, Alejandro F. Alice, Jason Baird, Terry Medler, Kristina H. Young, Marka R. Crittenden, et al.423102 CD8-BV570 (53-6.7),BioLegend,Cat #: 100740; RRID: AB_2563055 CD62L-BV605 (MEL-14),BioLegend,Cat #: 104438; RRID: AB_2563058 IL-10-BV650 (JES5-16E3),BioLegend,Cat #: 505039; RRID: AB_3097267 CXCR3-BV650 (CXCR3-173),BioLegend,Cat

(12) Tim-3 Promotes Early Differentiation of Tbet + Effector T Cells During Acute Viral InfectionbioRxivJanuary 30, 2026Priyanka Manandhar, Emily Landy, Kanako Mori, Lawrence P. Kane(BioLegend, 564298), CD45.2 (BD, 564616), CD45.1 (BioLegend, 110724), CD44 (BD, 612799), CD62L (BioLegend, 104438), KLRG1 (Invitrogen, 46-5893-80), CD127 (Tonbo, 60-1271-U100), Tim-3 (BioLegend, 119721 and 119723),

(13) Distinct control of T cell proliferation and effector function by partitioning of intracellular sulfur from cysteinebioRxivJanuary 30, 2026Beth Kelly, Minsun Cha, Tatjana Gremelspacher, Jacob L. Martin, Massimo Andreis, Gustavo E. Carrizo, Mia Gidley, Michal A Stanczak, Petya Apostolova, David E. Sanin, et al.(clone IM7, Biolegend, 103040, 103006, 103008, 103012), anti-CD62L (clone MEL-14, Biolegend, 104424, 104438, 104453), anti-CD69 (clone H1.2F3, Biolegend, 104508), anti-CD45.1 (clone A20, Biolegend, 110739, 110718),

(14) High-Dimensional Single-Cell Analysis Reveals Coordinated Age-Dependent Neuroinflammatory Microglia-T cell Circuits in the BrainbioRxivDecember 13, 2025Md Akkas Ali, Md Hasanul Banna Siam, Donald Vardaman, Chase Bolding, J. Nicholas Brazell, Ashleigh D. Whatley, Christopher A. Risley, Harrison Tidwell, Syed Nakib Hossain, Juhi Samal, et al.(clone 2F1/KLRG1; BioLegend, Cat# 138421, Lot# B395543) CD62L BV605 (clone MEL-14; BioLegend, Cat# 104438, Lot# B386347) MHC II (I-A/I-E) BV711 (clone M5/114.15.2; BioLegend, Cat# 107643, Lot# B377900) CD45R/B220

(15) Temporal and context-dependent requirements for the transcription factor Foxp3 expression in regulatory T cellsNat ImmunolOctober 8, 2025Wei Hu, Gabriel A. Dolsten, Eric Y. Wang, Giorgi Beroshvili, Zhong-Min Wang, Aazam P. Ghelani, Lion F. K. Uhl, Regina Bou-Puerto, Xiao Huang, Anthony J. Michaels, et al.Biosciences, 741230, 1:800), anti-CD62L (MEL-14, BioLegend, 104441, 1:400), anti-CD62L (MEL-14, BioLegend, 104438, 1:1,600), anti-CTLA4 (UC10-4B9, BioLegend, 106323, 1:200), anti-CTLA4 (UC10-4B9, Thermo Fisher, 12-1522-82,

(16) Protocol for the coculture of murine vaginal epithelial organoids and T cells to induce resident memory CD8 T cell differentiationSTAR ProtocolsSeptember 19, 2025Julian C. Ramprashad, Ying Lin, Lalit K. BeuraRESOURCE,SOURCE,IDENTIFIER Antibodies,Antibodies,Antibodies ,, BV605 anti-CD62L antibody (use 1:200),BioLegend,104438 BV711 anti-CD45.1 antibody (use 1:200),BioLegend,110739 FITC anti-mouse CD103 antibody (use 1:100),BioLegend,121420 PE/Dazzle

(17) Enhancer-driven gene regulatory networks reveal transcription factors governing T cell adaptation and differentiation in the tumor microenvironmentImmunityJuly 8, 2025William D. Green, Amber Gomez, Alec L. Plotkin, Brandon M. Pratt, Emily F. Merritt, Genevieve N. Mullins, Nancy P. Kren, Jennifer L. Modliszewski, Vasyl Zhabotynsky, Mark G. Woodcock, et al.TCF1/TCF7,Cell Signaling,Cat#9066;RRID:AB_2797696;Clone:C63D9 BV605 rat anti-mouse CD62L,BioLegend,Cat#104437;RRID:AB_11125577;Clone:MEL-14 BV711 rat anti-mouse CD8a,BioLegend,Cat#100747;RRID:AB_11219594;Clone:53-6.7 APC

(18) CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular primingNature ImmunologyJune 30, 2025Valentina Venzin, Cristian G. Beccaria, Chiara Perucchini, Pietro Delfino, Elisa B. Bono, Leonardo Giustini, Federica Moalli, Marta Grillo, Valeria Fumagalli, Chiara Laura, et al.(clone A20, 110743; 1:300 dilution), anti-CD4 (GK1.5, 100480; 1:200 dilution), anti-CD62L (MEL-14, 104438, 104453; 1:200 dilution), anti-CD80 (16-10A1, 104738; 1:100 dilution), anti-CD25 (PC61, 102075, 102020;

(19) De-coupling immune parameters and toxicity associated with IL-12 agonismCell ReportsJune 24, 2025Zachary R. Lanzar, Daniel L. Aldridge, Bhargavi Jayaraman, Breanne Haskins, Christian A. Howard, Kathya Arana, Molly E. Bunkofske, Kathleen Mulka, Ryan D. Pardy, Jessica Byerly, et al.Biosciences,Catalog: 755682; RRID:AB_3688014 Rat anti-mouse CD62L (clone: MEL-14) BV605,Biolegend,Catalog: 104437; RRID: AB_2563058 Rat anti-mouse CD62L (clone: MEL-14) BV711,Biolegend,Catalog: 104445; RRID: AB_2564215 Rat

(20) Temporal and Context-Dependent Requirements for the Transcription Factor Foxp3 Expression in Regulatory T CellsResearch SquareMay 14, 2025Alexander Rudensky, Gabriel Dolsten, Gabriel Beroshvili, Eric Y. Beroshvili, Zhong-Min Wang, Zhong-Min Ghelani, Lion F. K. Ghelani, Regina Bou Puerto, Regina Bou Puerto, Anthony J. Michaels, et al.Biosciences, 741230, 1:800), anti-CD62L (MEL-14, BioLegend, 104441, 1:400), anti-CD62L (MEL-14, BioLegend, 104438, 1:1,600), anti-CTLA4 (UC10–4B9, BioLegend, 106323, 1:200), anti-CTLA4 (UC10–4B9, Thermo Fisher, 12-1522-82,

Write a Review

(1)

12/15/2022Good Option to Stain for CD62L Elodie MohrIn different healthy and pathological contexts, CD4 and CD8 T cells differentiate into a range of specialized effector and regulatory subsets. In mouse models of aging and autoimmune diseases we study... Read Review
(1)

11/20/2020Great Antibody to Detect CD62L Expression on T cells Minhee OhCD62L is a homing marker that is expressed on naive and memory T cells. This antibody detects CD62L expression using flow cytometry.
(1)

6/9/2020Gates Out CD62L+ or CD62L- Efficiently Meng SunDefinitely reliable and clean spread of lo and hi expression of CD62L.
(1)

12/27/2019Very Good CD62L Staining Hong SunVery bright staining for CD62L.
(1)

11/6/2018Great Antibody to Identify Naive/Memory T Cells Based on CD62L Expression Wei XuOur lab studies CD8 T cell differentiation and function. T cell subsets within the spleen and in vitro are generally defined by CD44 and CD62L surface expression. To identify these subsets, I profile ... Read Review
(1)

7/30/2018Great Antibody to Identify Naive/Memory T Cells Chirag PatelOur lab studies the role of mTOR signaling in CD8 T cell differentiation and function. T cell subsets are generally defined by the expression of CD62L and CD44. We routinely profile our T cells for ... Read Review
(1)

4/13/2018Staining Mouse Splenocytes With Anti-CD62L BV605 Adam GuessThis antibody was used to stain CD62L+ cells in mouse splenocytes. It was chosen because it is a commonly used clone for CD62L, BV605 is bright and works well with other fluorophores in the staining ... Read Review
(1)

2/15/2018Antibody Is Bright And Stains CD62L+ T Cells Well Rebecca GuyerOne of the projects in our lab is studying the role and function of T cells in an active influenza A viral infection. In order to do that, we need good antibodies to identify different classes of T ... Read Review

Brilliant Violet 605™ anti-mouse CD62L from BioLegend

Description

BioLegend

Citations (104)

Reviews

Brilliant Violet 605™ anti-mouse CD62L from BioLegend

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map